Ruxience 500 MG/50 ML vial 50ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0B0P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,090
Award facts
- Contract value 100% obligated
- $10,090.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 30, 2026, to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency, provides $10,090.20 in firm fixed-price pharmaceutical products—specifically 500 mg/50 mL vials of Ruxience. The award is unset-aside and competitively awarded, with performance expected at the contractor's Conshohocken, Pennsylvania facility through February 2, 2026. Ruxience is a biosimilar to rituximab used in the treatment of various cancers and autoimmune conditions, reflecting the Defense Logistics Agency's role in supplying critical medications to military healthcare systems.
This delivery order executes against Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying a comprehensive portfolio of pharmaceutical products and medical supplies to military treatment facilities and veterans' healthcare programs globally. Through this prime contract, Amerisourcebergen demonstrates its capability to efficiently fulfill federal medical procurement requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0B0P?
SPE2DR26F0B0P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F0B0P worth?
The government has obligated $10,090 on SPE2DR26F0B0P.
Is contract SPE2DR26F0B0P an order under another contract?
Yes. SPE2DR26F0B0P is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0B0P competed?
The extent of competition for SPE2DR26F0B0P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award